1,1-dichloroethene increases expression ISO RGD:733540 6480464 vinylidene chloride results in increased expression of AOX1 mRNA CTD PMID:26682919 17alpha-ethynylestradiol decreases expression ISO RGD:620528 6480464 Ethinyl Estradiol results in decreased expression of AOX1 mRNA CTD PMID:17557909 17beta-estradiol decreases expression ISO RGD:620528 6480464 Estradiol results in decreased expression of AOX1 mRNA CTD PMID:24894866 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of AOX1 mRNA CTD PMID:19619570 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of AOX1 mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO RGD:620528 6480464 resveratrol inhibits the reaction [Estradiol results in decreased expression of AOX1 mRNA], resveratrol inhibits the reaction [Estradiol results in decreased expression of AOX1] CTD PMID:24894866 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:733540 6480464 2 more ... CTD PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:733540 6480464 2 more ... CTD PMID:20005886 , PMID:21851831 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:25305463 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AOX1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733540 6480464 Tetrachlorodibenzodioxin affects the expression of AOX1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733540 6480464 Tetrachlorodibenzodioxin results in increased expression of AOX1 mRNA, Tetrachlorodibenzodioxin results in increased expression of AOX1 protein CTD PMID:15664268 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AOX1 mRNA CTD PMID:23669205 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:620528 6480464 Tetrachlorodibenzodioxin results in increased expression of AOX1 mRNA CTD PMID:20558275 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620528 6480464 Tetrachlorodibenzodioxin results in decreased expression of AOX1 mRNA CTD PMID:21215274 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:733540 6480464 Tetrachlorodibenzodioxin results in increased activity of AOX1 protein CTD PMID:16292751 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733540 6480464 2 more ... CTD PMID:15664268 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of AOX1 mRNA CTD PMID:19619570 2,6-dinitrotoluene affects expression ISO RGD:620528 6480464 2, 6-dinitrotoluene affects the expression of AOX1 mRNA CTD PMID:21346803 2-acetamidofluorene multiple interactions ISO RGD:620528 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of AOX1 mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AOX1 mRNA CTD PMID:14656948 , PMID:16158176 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:620528 6480464 3 more ... CTD PMID:23196670 3,4-dichloroaniline decreases expression EXP 6480464 3, 4-dichloroaniline results in decreased expression of AOX1 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AOX1 mRNA CTD PMID:28628672 4-hydroxynon-2-enal increases expression ISO RGD:733540 6480464 4-hydroxy-2-nonenal results in increased expression of AOX1 mRNA CTD PMID:19191707 6alpha-methylprednisolone increases expression EXP 6480464 Methylprednisolone results in increased expression of AOX1 mRNA CTD PMID:19192274 acetamide decreases expression ISO RGD:620528 6480464 acetamide results in decreased expression of AOX1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:733540 6480464 Aflatoxin B1 results in increased expression of AOX1 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of AOX1 gene CTD PMID:27153756 all-trans-retinol multiple interactions ISO RGD:733540 6480464 [Tetrachlorodibenzodioxin co-treated with Vitamin A] results in increased activity of AOX1 protein more ... CTD PMID:16292751 alpha-D-galactose increases expression EXP 6480464 Galactose results in increased expression of AOX1 mRNA CTD PMID:23274001 alpha-D-galactose multiple interactions EXP 6480464 sodium bisulfide inhibits the reaction [Galactose results in increased expression of AOX1 mRNA] CTD PMID:23274001 ammonium chloride affects expression ISO RGD:620528 6480464 Ammonium Chloride affects the expression of AOX1 mRNA CTD PMID:16483693 azathioprine increases expression EXP 6480464 Azathioprine results in increased expression of AOX1 mRNA CTD PMID:19192274 belinostat decreases expression EXP 6480464 belinostat results in decreased expression of AOX1 mRNA CTD PMID:27188386 benzo[a]pyrene increases mutagenesis EXP 6480464 Benzoapyrene results in increased mutagenesis of AOX1 gene CTD PMID:25435355 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of AOX1 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation EXP 6480464 Benzoapyrene results in decreased methylation of AOX1 exon, Benzoapyrene results in decreased methylation of AOX1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:733540 6480464 Benzoapyrene results in increased methylation of AOX1 exon, Benzoapyrene results in increased methylation of AOX1 intron CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of AOX1 mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene increases expression ISO RGD:733540 6480464 Benzoapyrene results in increased expression of AOX1 mRNA CTD PMID:19770486 more ... benzo[b]fluoranthene decreases expression ISO RGD:733540 6480464 benzobfluoranthene results in decreased expression of AOX1 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of AOX1 mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:620528 6480464 bisphenol A results in increased expression of AOX1 mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:620528 6480464 bisphenol A affects the expression of AOX1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:733540 6480464 bisphenol A results in increased expression of AOX1 mRNA CTD PMID:30790712 bisphenol A increases methylation ISO RGD:620528 6480464 bisphenol A results in increased methylation of AOX1 gene CTD PMID:28505145 buta-1,3-diene increases expression ISO RGD:733540 6480464 1, 3-butadiene results in increased expression of AOX1 mRNA CTD PMID:29038090 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of AOX1 mRNA CTD PMID:26079696 cadmium sulfide increases expression EXP 6480464 cadmium sulfide results in increased expression of AOX1 mRNA CTD PMID:27866839 carbon nanotube decreases expression ISO RGD:733540 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbonyl sulfide increases expression ISO RGD:620528 6480464 carbonyl sulfide results in increased expression of AOX1 mRNA CTD PMID:19395590 cerium trichloride multiple interactions EXP 6480464 [cerous chloride co-treated with lanthanum chloride] results in increased expression of AOX1 mRNA CTD PMID:28954213 chenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA CTD PMID:32152650 chitosan multiple interactions ISO RGD:620528 6480464 [Chitosan co-treated with Fish Oils] inhibits the reaction [Dietary Fats results in decreased expression of AOX1 mRNA], Chitosan inhibits the reaction [Dietary Fats results in decreased expression of AOX1 mRNA] CTD PMID:28987369 chlorohydrocarbon multiple interactions ISO RGD:620528 6480464 [Hydrocarbons more ... CTD PMID:30744511 chloroprene increases expression ISO RGD:733540 6480464 Chloroprene results in increased expression of AOX1 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:733540 6480464 Chlorpyrifos results in decreased expression of AOX1 mRNA CTD PMID:32955216 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of AOX1 mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:733540 6480464 Clobetasol results in increased expression of AOX1 mRNA CTD PMID:27462272 cobalt dichloride increases expression ISO RGD:620528 6480464 cobaltous chloride results in increased expression of AOX1 mRNA CTD PMID:24386269 copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of AOX1 mRNA CTD PMID:20971185 copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of AOX1 mRNA CTD PMID:20971185 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of AOX1 mRNA CTD PMID:19549813 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of AOX1 mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA CTD PMID:32152650 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of AOX1 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO RGD:733540 6480464 Cyclosporine results in decreased expression of AOX1 mRNA CTD PMID:19770486 , PMID:23830897 cyfluthrin increases expression EXP 6480464 cyfluthrin results in increased expression of AOX1 mRNA CTD PMID:31330490 cyfluthrin multiple interactions EXP 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of AOX1 mRNA] CTD PMID:31330490 deoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA CTD PMID:32152650 dexamethasone multiple interactions ISO RGD:620528 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of AOX1 mRNA] CTD PMID:20032058 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AOX1 mRNA CTD PMID:28628672 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of AOX1 mRNA CTD PMID:25047013 dexamethasone increases expression ISO RGD:620528 6480464 Dexamethasone results in increased expression of AOX1 mRNA CTD PMID:20032058 dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of AOX1 mRNA CTD PMID:28302478 dieldrin multiple interactions ISO RGD:733540 6480464 NR1I3 protein affects the reaction [Dieldrin results in increased expression of AOX1 mRNA] CTD PMID:32435917 dieldrin increases expression ISO RGD:733540 6480464 Dieldrin results in increased expression of AOX1 mRNA CTD PMID:32435917 dioxygen multiple interactions ISO RGD:733540 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AOX1 mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron metabolite results in decreased expression of AOX1 mRNA CTD PMID:24172598 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin affects response to substance EXP 6480464 AOX1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 elemental selenium multiple interactions ISO RGD:620528 6480464 Selenium deficiency results in decreased expression of and results in decreased activity of AOX1 protein CTD PMID:19182374 elemental selenium decreases expression ISO RGD:620528 6480464 Selenium deficiency results in decreased expression of AOX1 mRNA CTD PMID:19182374 ethanol multiple interactions EXP 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AOX1 mRNA CTD PMID:29432896 ethanol increases expression ISO RGD:733540 6480464 Ethanol results in increased expression of AOX1 mRNA CTD PMID:30319688 fipronil increases expression ISO RGD:620528 6480464 fipronil results in increased expression of AOX1 mRNA CTD PMID:31881178 flutamide increases expression ISO RGD:620528 6480464 Flutamide results in increased expression of AOX1 mRNA CTD PMID:24136188 flutamide decreases expression ISO RGD:620528 6480464 Flutamide results in decreased expression of AOX1 mRNA CTD PMID:24793618 galactose increases expression EXP 6480464 Galactose results in increased expression of AOX1 mRNA CTD PMID:23274001 galactose multiple interactions EXP 6480464 sodium bisulfide inhibits the reaction [Galactose results in increased expression of AOX1 mRNA] CTD PMID:23274001 glycidol increases expression ISO RGD:620528 6480464 glycidol results in increased expression of AOX1 mRNA CTD PMID:24915197 glycochenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA CTD PMID:32152650 glycocholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA CTD PMID:32152650 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AOX1 mRNA CTD PMID:28628672 isobutanol multiple interactions EXP 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AOX1 mRNA CTD PMID:29432896 isoflavones affects expression EXP 6480464 Isoflavones affects the expression of AOX1 mRNA CTD PMID:16365062 isoprenaline increases expression ISO RGD:733540 6480464 Isoproterenol results in increased expression of AOX1 mRNA CTD PMID:20003209 leflunomide increases expression ISO RGD:620528 6480464 leflunomide results in increased expression of AOX1 mRNA CTD PMID:24136188 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of AOX1 mRNA] CTD PMID:31330490 menadione multiple interactions EXP 6480464 Vitamin K 3 inhibits the reaction [AOX1 protein results in increased metabolism of zoniporide] CTD PMID:20040581 menadione decreases activity EXP 6480464 Vitamin K 3 results in decreased activity of AOX1 protein CTD PMID:20040581 mercury dibromide decreases expression EXP 6480464 mercuric bromide results in decreased expression of AOX1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of AOX1 mRNA CTD PMID:27188386 methapyrilene decreases expression ISO RGD:620528 6480464 Methapyrilene results in decreased expression of AOX1 mRNA CTD PMID:30467583 methotrexate affects metabolic processing EXP 6480464 AOX1 protein affects the metabolism of Methotrexate CTD PMID:20444863 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of AOX1 mRNA CTD PMID:24449571 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of AOX1 mRNA CTD PMID:19192274 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of AOX1 mRNA CTD PMID:28001369 methylmercury chloride multiple interactions ISO RGD:620528 6480464 [Hydrocarbons more ... CTD PMID:30744511 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of AOX1 mRNA CTD PMID:29581082 mitomycin C affects response to substance EXP 6480464 AOX1 protein affects the susceptibility to Mitomycin CTD PMID:16217747 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-2-ethylhexylphthalate results in increased expression of AOX1 mRNA CTD PMID:23360888 N-methylformamide increases expression ISO RGD:733540 6480464 methylformamide analog results in increased expression of AOX1 mRNA, methylformamide results in increased expression of AOX1 mRNA CTD PMID:17040096 N-nitrosodiethylamine multiple interactions ISO RGD:620528 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of AOX1 mRNA, [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AOX1 mRNA CTD PMID:14656948 , PMID:16158176 nefazodone increases expression ISO RGD:620528 6480464 nefazodone results in increased expression of AOX1 mRNA CTD PMID:24136188 nefazodone multiple interactions EXP 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AOX1 mRNA CTD PMID:32152650 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of AOX1 mRNA CTD PMID:32152650 nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of AOX1 mRNA CTD PMID:22714537 nitrogen dioxide increases expression EXP 6480464 Nitrogen Dioxide results in increased expression of AOX1 mRNA CTD PMID:27206323 ozone decreases expression ISO RGD:733540 6480464 Ozone results in decreased expression of AOX1 mRNA CTD PMID:12763052 p-chloromercuribenzoic acid decreases expression EXP 6480464 p-Chloromercuribenzoic Acid results in decreased expression of AOX1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of AOX1 mRNA CTD PMID:27188386 p-toluidine increases expression ISO RGD:620528 6480464 4-toluidine results in increased expression of AOX1 mRNA CTD PMID:27638505 paclitaxel affects response to substance EXP 6480464 AOX1 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 panobinostat decreases expression EXP 6480464 panobinostat results in decreased expression of AOX1 mRNA CTD PMID:26272509 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of AOX1 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:733540 6480464 Acetaminophen affects the expression of AOX1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of AOX1 mRNA CTD PMID:29067470 pentachlorophenol increases expression ISO RGD:733540 6480464 Pentachlorophenol results in increased expression of AOX1 mRNA CTD PMID:23892564 pentanal increases expression EXP 6480464 pentanal results in increased expression of AOX1 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:620528 6480464 perfluorooctane sulfonic acid results in decreased expression of AOX1 mRNA CTD PMID:18692542 perfluorooctanoic acid affects expression ISO RGD:733540 6480464 perfluorooctanoic acid affects the expression of AOX1 mRNA CTD PMID:18281256 perfluorooctanoic acid multiple interactions EXP 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of AOX1 mRNA CTD PMID:33325755 permethrin increases expression ISO RGD:733540 6480464 Permethrin results in increased expression of AOX1 mRNA CTD PMID:30629241 phenobarbital multiple interactions ISO RGD:733540 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of AOX1 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:733540 6480464 Phenobarbital affects the expression of AOX1 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:733540 6480464 Phenobarbital results in increased expression of AOX1 mRNA CTD PMID:19482888 more ... phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of AOX1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of AOX1 mRNA CTD PMID:27188386 phlorizin decreases expression ISO RGD:733540 6480464 Phlorhizin results in decreased expression of AOX1 mRNA CTD PMID:22538082 phytoestrogen multiple interactions EXP 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of AOX1 mRNA CTD PMID:33325755 pirinixic acid decreases expression ISO RGD:733540 6480464 pirinixic acid results in decreased expression of AOX1 mRNA CTD PMID:18445702 pirinixic acid increases expression ISO RGD:733540 6480464 pirinixic acid results in increased expression of AOX1 mRNA CTD PMID:23811191 potassium chromate decreases expression EXP 6480464 potassium chromateVI results in decreased expression of AOX1 mRNA CTD PMID:22714537 prednisolone increases expression EXP 6480464 Prednisolone results in increased expression of AOX1 mRNA CTD PMID:19192274 progesterone increases expression EXP 6480464 Progesterone results in increased expression of AOX1 mRNA CTD PMID:21540246 , PMID:21795739 progesterone increases expression ISO RGD:620528 6480464 Progesterone results in increased expression of AOX1 mRNA CTD PMID:20726854 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of AOX1 mRNA CTD PMID:26079696 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of AOX1 mRNA CTD PMID:21632981 raloxifene decreases activity EXP 6480464 Raloxifene Hydrochloride results in decreased activity of AOX1 protein CTD PMID:20040581 raloxifene multiple interactions EXP 6480464 Raloxifene Hydrochloride inhibits the reaction [AOX1 protein results in increased metabolism of zoniporide] CTD PMID:20040581 resveratrol multiple interactions ISO RGD:620528 6480464 resveratrol inhibits the reaction [Estradiol results in decreased expression of AOX1 mRNA], resveratrol inhibits the reaction [Estradiol results in decreased expression of AOX1] CTD PMID:24894866 resveratrol affects expression ISO RGD:733540 6480464 resveratrol affects the expression of AOX1 mRNA CTD PMID:23525482 rofecoxib decreases expression EXP 6480464 rofecoxib results in decreased expression of AOX1 mRNA CTD PMID:17070997 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:620528 6480464 Selenium deficiency results in decreased expression of and results in decreased activity of AOX1 protein CTD PMID:19182374 selenium atom decreases expression ISO RGD:620528 6480464 Selenium deficiency results in decreased expression of AOX1 mRNA CTD PMID:19182374 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of AOX1 mRNA, Silicon Dioxide results in increased expression of AOX1 mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of AOX1 mRNA CTD PMID:23806026 silver atom increases expression ISO RGD:733540 6480464 Silver results in increased expression of AOX1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:733540 6480464 Silver results in increased expression of AOX1 mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:620528 6480464 sodium arsenite results in increased expression of AOX1 protein CTD PMID:29459688 sodium aurothiomalate increases expression EXP 6480464 Gold Sodium Thiomalate results in increased expression of AOX1 mRNA CTD PMID:19192274 succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AOX1 mRNA CTD PMID:26378955 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of AOX1 mRNA CTD PMID:15336504 testosterone increases expression ISO RGD:733540 6480464 Testosterone results in increased expression of AOX1 mRNA CTD PMID:21669218 testosterone multiple interactions ISO RGD:620528 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of AOX1 mRNA] CTD PMID:20032058 tetrachloromethane decreases expression ISO RGD:733540 6480464 Carbon Tetrachloride results in decreased expression of AOX1 mRNA CTD PMID:17484886 , PMID:31919559 topotecan affects response to substance EXP 6480464 AOX1 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of AOX1 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO RGD:733540 6480464 trimellitic anhydride results in decreased expression of AOX1 mRNA CTD PMID:19042947 triphenyl phosphate increases expression ISO RGD:620528 6480464 triphenyl phosphate results in increased expression of AOX1 mRNA CTD PMID:30589522 triptonide decreases expression ISO RGD:733540 6480464 triptonide results in decreased expression of AOX1 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris2-butoxyethyl phosphate affects the expression of AOX1 mRNA CTD PMID:29024780 tungstate multiple interactions ISO RGD:733540 6480464 tungstate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AOX1 protein] CTD PMID:15664268 tungstate decreases expression ISO RGD:733540 6480464 tungstate results in decreased expression of AOX1 protein CTD PMID:15664268 urethane decreases expression EXP 6480464 Urethane results in decreased expression of AOX1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:733540 6480464 Valproic Acid affects the expression of AOX1 mRNA CTD PMID:17292431 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of AOX1 mRNA CTD PMID:24383497 more ... valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of AOX1 gene CTD PMID:29154799 vincaleukoblastine affects response to substance EXP 6480464 AOX1 protein affects the susceptibility to Vinblastine CTD PMID:16217747 zaleplon affects metabolic processing EXP 6480464 AOX1 protein affects the metabolism of zaleplon CTD PMID:20444863 zinc atom decreases expression ISO RGD:620528 6480464 Zinc deficiency results in decreased expression of AOX1 mRNA CTD PMID:12672911 zinc(0) decreases expression ISO RGD:620528 6480464 Zinc deficiency results in decreased expression of AOX1 mRNA CTD PMID:12672911
